Tuberculosis in patients with HIV infection;Tuberculosis en pacientes infectados por el VIH

Anales del Sistema Sanitario de Navarra

Volumn 30, Issue SUPPL. 2, 2007, Pages 131-142

  Úriz Ayestarán, Javier ^a,b   Repáraz, Jesús ^a,b   Castiello, J ^a   Sola, J ^a  

^a Universidad Pública de Navarra

^b Servicio de Enfermedades Infecciosas   (Spain)

Author keywords

AIDS; HIV; Non tuberculosis mycobacteria; Treatment; Tuberculosis

Indexed keywords

AMIKACIN; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BCG VACCINE; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TUBERCULOSTATIC AGENT;

BCG VACCINATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; INOCULATION; LUNG TUBERCULOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PROGNOSIS; REINFECTION; REVIEW; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOUS MENINGITIS;

HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 34848843264     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. BARRÉ SINOUSSI F, CHERMANN JC, REY F, NUGEYRE MT, CHAMARET S, GRUEST J et al. Isolation of a T-lynphotropic retrovirus from a patient at risk for acquirided inmunodeficiency síndrome (AIDS). Science 1983; 220: 868-871.
2. FAUCI AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Sciencie 1988; 239: 617-622.
3. PITCHENIK AE, FERTEL D. Tuberculosis and nontuberculous mycobacterial disease. En: Medical management of AIDS patiens. The Medical Clinics of North America 1991; 1.
4. PITCHENIK AE. Tuberculosis control and the AIDS epidemic in developing countries. Ann Intern Med 1991; 113: 89-91.
5. BUCHER HC, GRIFFITH LE, GUYATT GH, SUDRE P, NAEF M, SENDI P et al. Isoniacid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomizes controlled trials. AIDS 1999; 13: 501-507.
6. DALEY CL, SMALL PM, SCHERTE GF, SCHOOLNIK GK, MCADAM RA, JACOBS WR et al. An outbreak of tuberculosis with accelerated progresion among persons infected with the human inmunodeficiency virus: an analysis using retriction-fragment- length polymorphisms. N Engl J Med 1992; 326: 231-235.
7. Reported tuberculosis in the United States 2000. Center for Disease Control and Prevetion, August 2001.
8. Sistema Estatal de Información sobre VIH y SIDA. Registro Nacional de nuevos casos. Situación a 31 de diciembre. En www.isciii.es/htdocs/ centros/epidemiologia/epi_sida.jsp.
9. Who Repot 2007. Global Tuberculosis Control Surveillance, Planning, Finnancing. En: www.who.int/tb/publications/global_repots/en/index.html.
10. GANDHI NR, MOLL A, STURM AW, PAWINSKI R, GOVENDER T, LALLOO U et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in rural area of South Africa. Lancet 2006; 368: 1575-1580.
11. ALCAMÍ J. Avances en la inmunopatología de la infección por el VIH. Enferm Infecc Microbiol Clin 2004; 22: 486-496.
12. URIZ J, SOLA J, CASTIELLO J, REGALADO J, KUTZ M. Mycobacterium tuberculosis y SIDA. II Congreso Nacional sobre el SIDA. Bilbao 1993. Abstract C-112.
13. SMALL PM, SHAFFER RW, HOPEWEL PC, SIGH P, MURPHY MJ, DESMOND E et al. Exogenous reinfection with multidrug-resistent Mycobacterium tuberculosis with advanced HIV infection. N England J Med 328: 1137-1144.
14. FISCHL MA, UTTAMCHANDANI RB, DAIKOS GL, POBLETE RB, MORENO JN, REYES RR et al. An outbreak of tuberculosis caused by multiple drug-resistant among patients wih HIV infection. Ann Inter Med 1992; 117: 177-183.
15. SORIANO E, MALLOLAS J, GATELL JM, LATORRE X, MIRO JM, PECHIAR M et al. Characteristics of tuberculosis in HIV infected patients: a case control study. AIDS 1998; 2: 429-433.
16. ROMERO J, ROCA V, PICAZO JJ, PALAU E, SANTILLANA T, DE LA TORRE F. Características de la tuberculosis en pacientes con infección por VIH. Enf Infecc Microbiol Clin 1991; 1Suppl: 38S-46S.
17. BOUZA, DIAZ MD, MORENO S, BERNARDO DE QUIRÓS JC, VICENTE T, BERENGUER J. Mycobacterium tuberculosis bacteriemia in patients with and without human inmunodeficiency virus infection. Arch Intern Med 1993; 153: 296-500.
18. FERNÁNDEZ A, ARAZO P, AGUIRRE JM, ARRIBAS JL. Tuberculosis pulmonar: diferencias entre pacientes seropositivos y seronegativos para el virus de la inmunodeficiencia humana. An Med Intern (Madrid) 1993; 10: 381-385.
19. BRINDLE RJ, NUNN PP, GITHUI W, ALLEN BW, GATHUA S, WAIYAKI P. Quantitative bacillary response to treatement in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis 1993; 147: 958-961.
20. GARCÍA-MARTOS P, CASTAÑO MA, CANUETO J, HÖHZ L, DÍAZ J, GONZÁLEZ-BORRACHERO ML. Tuberculosis en 34 pacientes con infección por VIH. Enf Infecc Microbiol Clin 1991; 9: 488-490.
21. PITHIE AD, CHICKSEN B. Fine-needle extrahoraric lymphnode aspiration in HIV-associated sputum-negative tuberculosis. Lancet 1992; 340: 1504-1505.
22. BERENGUER J, MORENO S, LAGUNA F, VICENTE T, ADRADES M, ORTEGA A et al. Tuberculous meningitis in patients infected with human inmonodeficiency virus. N Engl J Med 1992; 326: 668-672.
23. DUBÉ MP, HOLTOM PD, LARSEN RA. Tuberculous meningitis in patiens with and without immunodeficiency virus infection. Ann J Med 1992; 93: 520-524.
24. NAVARRO R, PÉREZ JA, CASTILLO M, ERRANDO E, ALOS M, GÓMEZ D. Tuberculosis miliar y tuberculosas cerebrales. A propósito de un caso. An Med Intern (Madrid) 1993; 10: 443-445.
25. BOTEL JP, MARISTANY MT, MIRALLES R, LÓPEZ-COLOMÉS JL, RUBIÉS J. Splenic tuberculous in patients with AIDS. Rev Infect Dis 1991; 13: 1069-1071.
26. MARTÍN I, AGUAYO DM, CORDERO F, PUJOL DE LA LLAVE E. Abscesos hepáticos tuberculosos como forma de presentación de la infección por el virus de la inmunodeficiencia humana. An Med Intern (Madrid) 1993; 10: 123-126.
27. EYER WA, DE SA CA, PINTO JF, GAMEIRO CA. Pancreatic tuberculosis as a manifestación the human inmunodeficiency virus (letter). Clin Infect Dis 1993; 16: 332.
28. BASCUÑANA A, TORRES A, PÉREZ M, LÓPEZ A, RENDÓN A, PÉREZ E. Abscesos abdominales tuberculosos en pacientes con síndrome de inmunodeficiencia adquirida: descripción de cinco caso. Med Clin (Barc) 1990; 95: 259-261.
29. FRIEDENBERG KA, DRAGUESKU JO, KIBAYU M, VALENZUALEA JE. Inestinal perforation due to Mycobacterium tuberculosis in HIV-infected individuals, Report of two cases. An J Gastroenterol 1993; 88: 604-607.
30. DE LA FUENTE J, PRIETO I, BORDÓ N J, FERNÁNDEZ P. Tuberculous siladenitis (letter). Med Clin (Barc); 100: 637.
31. MARTOS JA, OLM M, MIRÓ JM, MALLOTAS J, LETANG E, BRANCOS MA et al. Tuberculosis condrocostal y condroesternal en dos heroinómanos infectados por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1989; 93: 467-470.
32. SHAFER RW, KIM DS, WEISS JP, QUALE JM. Extrapulmonary tuberculosis in patients with human inmodeficiency virus. Medicine (Baltimore) 1991; 70: 384-397.
33. DRONDA F, CHAVES F, GONZÁLEZ A, CATALÁN S, FERNÁNDEZ F. Bacteriemia por Mycobacterium tuberculosis en pacientes coinfectados por el virus de la inmunodeficiencia humana. Med Clin (Barc) 1993; 101: 534-537.
34. MATTAR S, MORTA M, DROBNIC L, HERNÁNDEZ P, PALLARÉS E, GIMENO JL et al. Sepsis por Mycobacterium tuberculosis en pacientes con SIDA. Enfer Infecc Microbiol Clin 1992; 10: 29-31.
35. DE SIMONA JA, POMERANTZ RJ, BABINCHAK TJ. Inflammatory reactions in VIH 1 infected persons after initiation of higly active antiretroviral therapy. Ann Intern Med 2000; 133: 447-454.
36. CHIEN JW, JHONSON JL. Paradoxical reaction in HIV and pulmonary TB. Chest 1998; 114: 933-936.
37. WELTMAR AC, ROSE DN. The safety of Bacille Calmette-Guerin vaccinaton in the HIV infection and AIDS. AIDS 1993; 7: 149-157.
38. JORDAN TJ, LEWIT EM, MONTGOMERY RL, REICHMAN LB. Isoniacid as preventive therapy in HIV-infected intravenous drug abusers. JAMA 1992; 265: 2987-2991.
39. DE MARCH P. Tuberculosis y SIDA. Situación en España. Perspectiva (editorial). Rev Clin Esp 1990; 186: 365-368.
40. American Thoracic Society and Centers for Diseases Control and Prevetion. Targeted tuberculin testing and teatrement of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161; S221-S247.
41. Hong Kong Chest Service/Tuberculosis Research Centre Madras/British Medical Research Council. A double blind placebo-controlled clinical trial of theree antituberculosis chemoprophylaxis regimens in patiens with silicosis in Hong Kong. An Rev Respir Dis 1992; 145: 36-41.
42. CAMINAL L, TRAPIELLA L, TELENTI M, FERNÁNDEZ BERNALDO DE QUIRÓS J. Caracteríticas de la tuberculosis en un hospital general durante el príodo 1993-1998. Análisis de resistencias e infección por VIH. Enferm Infecc Microbiol Clin 2002; 20: 68-73.
43. PODZAMCER D, ARRIBAS JR, MALLOTAS J, PEÑA JM, PULIDO F. Tratamiento de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el virus de la inmunodeficiencia humana en la era del tratamiento antirretroviral. Recomendaciones del Grupo de Estudio del Sida (GESIDA)/ Plan Nacional del Sida. Enferm Infecc Microbiol Clin 2001; 19: 376-392.
44. LÓPEZ-CORTES LF, RUIZ R, VICIANA P, ALARCÓN A, LEON E, SARASA M et al. Pharmacokinetic interactions betwen rifampicin and efavirenz in patines whith tuberculosis and HIV infection. Program and abstract of the 8th Conference on etrovirus and Opportunistic Infections; Febrery 4-8; 2001; Chicago, Illinois; Abstract 32.
45. STONEBURNER R, LAROCHE E, PREVOTS R, SINGH T, BLUM M, TERRY P et al. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patiens in New York City. Arch Intern Med 1992; 152: 2033-2037.
46. ISEMAN MD. Treatement of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
47. BERNING SE, HUITT GA, ISEMAN MD, PELOQUIN CA. Malabsorption of antituberculosis medications by a patient with AIDS (letter). N Engl J Med 1992; 327: 1817-1818.
48. DOOLEY SW, JARVIS WR, MARTONE WJ, SNIDER DE. Multidrug-resistant tuberculosis (editorials). Ann Int Med 1992; 117: 257-259.
49. PEARSON ML, JEREB JA, FRIEDEN TR, CRAWFORD JT, DAVIS BJ, COOLEY SW et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Ann Int Med 1992; 117:191-196.
50. FISCHL MA, DAIKOS GL, UTTAMCHANDANI RB, POBLETE RB, MORENO JN, REYES RR et al. Clinical presentation and outcome of patiens with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Int Med 1992; 117: 184-190.
51. TIMPE A, RUNYON EH. The relationship of atypical acid-fast bacteria to human disease. J Lab Clin Med 1954; 44: 202-209.
52. WALLER EA, ROY A, BRUMBLE L, KHOOR A, JOHNSON MM, GARLAND JL. The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease. Chest 2006; 130:1234-1241.
53. YAMAMOTO M. Pulmonary disease due to Mycobacterium kansasii in Japan. Intern Med 1997; 36: 240-241.
54. JINDAL N, DEVI B, AGGARWAL A. Mycobacterial cervical lymphadenitis in childhood. Indian J Med Sci 2003; 57: 12-15.
55. LIAO CH, LAI CC, DING LW, HOU SM, CHIU HC, CHANG SC et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 2007; 11: 96-102.
56. GLICKSTEIN SL, NASHEL DJ. Mycobacterium kansasii septic arthritis complicating rheumatic disease: case report and review of the literature. Semin Arthritis Reum 1987; 16: 231-235.
57. COITINHO C, BRANDES E, PARDINAS M, RIVAS C. Disseminated mycobacterial infections in patients with AIDS. Evaluation of blood cultures. Rev Argent Microbiol 2005; 37; 196-198.
58. PARENTI DM, SYMINGTON JS, KEISER J, SIMON GL. Mycobacterium kansasii bacteremia in patients infected with HIV. Clin Infect Dis 1995; 21: 1001-1003.
59. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care 1997; 156: 1-25.
60. SHAFRAN SD, MASHINTER LD, PHILLIPS P, LALONDE RG, GILL MJ, WALMSLEY SL et al. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy. Ann Intern Med 2002; 137: 734-737.
61. HORSBURGH CR JR, GETTINGS J, ALEXANDER LN, LENNOX JL. Disseminated Mycobacterium avium complex disease among patients infected with HIV. Clin Infect Dis 2001; 33: 1938-1943.
62. HEWITT RG, PAPANDONATOS GD, SHELTON MJ, HSIAO CB, HARMON BJ, KACZMAREK SR et al. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. AIDS 1999; 13; 1367-1372.
63. EVANS SA, COLVILLE A, EVANS AJ, CRISP AJ, JOHNSTON IDA. Pulmonary Mycobacterium kansasii infection: comparison of clinical features, treatment and outcome with pulmonary tuberculosis. Thorax 1996; 51: 1248-1252.
64. CARPENTER JL, PARKS JM. Mycobacterium kansasii infections in patients positive for HIV. Clin Infect Dis 1991; 13: 789-796.
65. STURENBURG EE, HORSKOTTE MA, ABERLE J, MEYER K, RICHTER E, LAUFS R et al. Disseminated Mycobacterium haemophilum infection as initial manifestation of AIDS. Tuberculosis 2004; 84: 341-345.
66. PIERSIMONI C, TORTOLI E, DE LALLA F, NISTA D, DONATO D, BORMIGIA S et al. Isolation of Mycobacterium celatum from patients infected with HIV. Clin Infect Dis 1997; 24: 144-147.
67. SAMPAIO JL, ARTILES N, PEREIRA RM, SOUZA JR, LEITE JP. Mycobacterium simiae infection in a patient with AIDS. Braz J Infect Dis 2001; 5: 352-355.
68. FAKIH M, CHAPALAMADUGU S, RICART A, CORRIERE N, AMSTERDAM D. Mycobacterium malmoense bacteremia in two AIDS patients. J Clin Microbiol 1996; 34: 731-733.
69. BÖTTGER EC, TESKE A, KIRSCHNER P, BOST S, CHANG HR, BEER V et al. Disseminated Mycobacterium genavense infection in patients with AIDS. Lancet 1992; 340: 76-80.
70. THOMSEN VO, DRAGSTED UB, BAUER J, FUURSTED K, LUNDGREN J. Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol 1999: 37: 3901-3905.
71. BESSESEN MT, SHLAY J, STONE-VENOHR B, COHN DL, REVES RR. Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy. AIDS 1993; 7: 1357-1361.